Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
http://finance.yahoo.com/q?s=PSTI
PSTI completes dosing with first group of patients in Europe/ may start treatment with larger group with second phase dosing for P.A.D.